Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
Status:
Terminated
Trial end date:
2016-08-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetic and
pharmacodynamic effects of single doses of Neu-120 in Parkinson's disease patients with
levodopa-induced dyskinesia.